The Rationale for Utilizing an Optimized Formulary to Improve the Health and Economic Outcomes of Patients with Multiple Sclerosis

August 1, 2004

The objective of this supplement is to alert managed care decision makers nationwide to how the evolution of biologics will affect both their organizations and the health and well-being of their patient populations.